Las Vegas, NV -- (SBWIRE) -- 01/28/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: KB Home (NYSE:KBH), Kinross Gold Corporation (USA) (NYSE:KGC), InfoSonics Corporation (NASDAQ:IFON), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA).
KB Home (NYSE:KBH) ended its recent business day with the tumbled of -2.72% and closed at the price of $17.55 after opening at $17.75. The stock traded during its last trading session with the total volume of 7.99 million shares, as compared to its average volume of 3.62 million shares. KB Home operates as a homebuilding and financial services company in the United States.
Has KBH Found The Bottom And Ready To Gain Momentum? Find Out Here
Kinross Gold Corporation (USA) (NYSE:KGC) remained among the day bearish -3.44% and traded with volume of 9.33 million shares in the last session, as compared to average volume of 10.72 million shares. In comparison with 52 week range of $4.23 - $8.95, it faced lowest price of $4.49 during the last trading session whereas its day highest price was $4.61. The company’s total market capitalization is $5.13 billion, along with 1.14 billion shares outstanding. Kinross Gold Corporation, together with its subsidiaries, engages in mining and processing gold and silver ores. It is involved in the exploration, acquisition, development, and operation of gold bearing properties.
Why Should Investors Buy KGC After the Recent Fall? Just Go Here and Find Out
InfoSonics Corporation (NASDAQ:IFON) showed 2.89 million shares in volume during the last trading session, while the average trading volume remained 646,420.00 shares. The stock kicked off its trading session at $2.17 and closed at $2.92 after rallied 41.75%. InfoSonics Corporation designs, develops, manufactures, and sells wireless telecommunication products and accessories to wireless carriers, distributors, retailers, dealer agents, resellers, and original equipment manufacturers.
Why Should Investors Buy IFON After The Recent Gain? Just Go Here and Find Out
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock traded during its last trading session with the total traded volume of 7.90 million shares versus its average volume of 5.49 million shares. The company opened its trade at the price of $7.38 and its closing price was $6.93 after fell -5.33% for the day. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Has ARNA Found The Bottom and Ready To Move Up? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)